Načítá se...
Optimizing the Use of Neoadjuvant Endocrine Therapy
Nowadays, neoadjuvant endocrine therapy is a clinically acceptable (and sometimes preferred) strategy in patients with operable estrogen receptor-positive (ER+) breast cancer. Despite the overall effectiveness of endocrine therapy in breast cancer in all settings, de novo (primary) and acquired (sec...
Uloženo v:
| Vydáno v: | Curr Oncol Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5524371/ https://ncbi.nlm.nih.gov/pubmed/26008918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-015-0455-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|